Literature DB >> 21298332

Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.

Catherine M L Foy1, Eileen M Daly, Amanda Glover, Ruth O'Gorman, Andrew Simmons, Declan G M Murphy, Simon Lovestone.   

Abstract

Proton magnetic resonance spectroscopy ((1)H-MRS) studies have previously reported reduced brain N-acetyl aspartate (NAA) and increased myo-inositol (mI) in people with established Alzheimer's disease (AD). The earliest structure affected by AD is the hippocampus but relatively few studies have examined its neuronal integrity by MRS in AD and fewer still in people with amnestic mild cognitive impairment (MCI). We measured the hippocampal concentration of NAA, mI, choline (Cho) and creatine + phosphocreatine (Cr + PCr) in 39 patients with AD, 21 subjects with MCI and 38 age matched healthy elderly controls. Patients with AD had a significantly lower hippocampal [NAA] than controls, with subjects with MCI intermediate between the other two groups. [NAA] was positively correlated with memory in the impaired groups. Using mean hippocampal [NAA] and [Cr + PCr] we correctly classified 72% of people with AD, and 75% of controls. Reductions in [NAA] can be detected in the hippocampi of subjects with MCI and hippocampal [NAA] and [Cr + PCr] can distinguish between mild AD and normal elderly controls.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21298332     DOI: 10.1007/s10548-011-0170-5

Source DB:  PubMed          Journal:  Brain Topogr        ISSN: 0896-0267            Impact factor:   3.020


  18 in total

1.  Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study.

Authors:  Burcu Zeydan; Dinesh K Deelchand; Nirubol Tosakulwong; Timothy G Lesnick; Orhun H Kantarci; Mary M Machulda; David S Knopman; Val J Lowe; Clifford R Jack; Ronald C Petersen; Gülin Öz; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2017-06-29       Impact factor: 2.486

2.  Fully automated atlas-based method for prescribing 3D PRESS MR spectroscopic imaging: Toward robust and reproducible metabolite measurements in human brain.

Authors:  Wei Bian; Yan Li; Jason C Crane; Sarah J Nelson
Journal:  Magn Reson Med       Date:  2017-05-03       Impact factor: 4.668

3.  Early differences in dorsal hippocampal metabolite levels in males but not females in a transgenic rat model of Alzheimer's disease.

Authors:  L H Nilsen; T M Melø; M P Witter; U Sonnewald
Journal:  Neurochem Res       Date:  2013-12-17       Impact factor: 3.996

4.  Potential clinical impact of multiparametric quantitative MR spectroscopy in neurological disorders: A review and analysis.

Authors:  Ivan I Kirov; Assaf Tal
Journal:  Magn Reson Med       Date:  2019-08-08       Impact factor: 4.668

Review 5.  Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies.

Authors:  Tao Song; Xiaopeng Song; Chenyawen Zhu; Regan Patrick; Miranda Skurla; Isabella Santangelo; Morgan Green; David Harper; Boyu Ren; Brent P Forester; Dost Öngür; Fei Du
Journal:  Ageing Res Rev       Date:  2021-10-29       Impact factor: 10.895

6.  Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.

Authors:  Aisling M Chaney; Francisco R Lopez-Picon; Sophie Serrière; Rui Wang; Daniela Bochicchio; Samuel D Webb; Matthias Vandesquille; Michael K Harte; Christina Georgiadou; Catherine Lawrence; Julie Busson; Johnny Vercouillie; Clovis Tauber; Frédéric Buron; Sylvain Routier; Tristan Reekie; Anniina Snellman; Michael Kassiou; Johanna Rokka; Karen E Davies; Juha O Rinne; Dervis A Salih; Frances A Edwards; Llwyd D Orton; Stephen R Williams; Sylvie Chalon; Hervé Boutin
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

7.  Relationships among serum C-reactive protein, receptor for advanced glycation products, metabolic dysfunction, and cognitive impairments.

Authors:  Xia Ge; Xiao-yun Xu; Chun-hua Feng; Yue Wang; Yuan-ling Li; Bo Feng
Journal:  BMC Neurol       Date:  2013-08-27       Impact factor: 2.474

8.  Dementia in Down's syndrome: an MRI comparison with Alzheimer's disease in the general population.

Authors:  Diane Mullins; Eileen Daly; Andrew Simmons; Felix Beacher; Catherine Ml Foy; Simon Lovestone; Brian Hallahan; Kieran C Murphy; Declan G Murphy
Journal:  J Neurodev Disord       Date:  2013-08-20       Impact factor: 4.025

Review 9.  Lower brain and blood nutrient status in Alzheimer's disease: Results from meta-analyses.

Authors:  Martijn C de Wilde; Bruno Vellas; Elodie Girault; Aysun Cetinyurek Yavuz; John W Sijben
Journal:  Alzheimers Dement (N Y)       Date:  2017-06-24

10.  Alzheimer-like brain metabolic and structural features in cholesterol-fed rabbit detected by magnetic resonance imaging.

Authors:  Ping Jin; Yongming Pan; Zhiyong Pan; Jianqin Xu; Min Lin; Zhichao Sun; Minli Chen; Maosheng Xu
Journal:  Lipids Health Dis       Date:  2018-03-27       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.